CYduct Diagnostics, Inc.
CYDX · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | – | $2,727 | $2,314 | $1,286 |
| - Cash | $1 | $30 | $55 | $272 |
| + Debt | $628 | $670 | $570 | $520 |
| Enterprise Value | – | $3,368 | $2,829 | $1,534 |
| Revenue | $71 | $84 | $119 | $94 |
| % Growth | -16.3% | -29.2% | 26.9% | – |
| Gross Profit | $47 | $57 | $83 | $64 |
| % Margin | 66.2% | 67% | 69.9% | 67.5% |
| EBITDA | -$363 | -$379 | -$441 | -$167 |
| % Margin | -513.8% | -448.5% | -369.7% | -177.5% |
| Net Income | -$414 | -$418 | -$473 | -$420 |
| % Margin | -585.1% | -494.8% | -396.1% | -447.1% |
| EPS Diluted | -0.079 | -0.08 | -0.093 | -0.082 |
| % Growth | 1.7% | 13.3% | -13.2% | – |
| Operating Cash Flow | -$72 | -$175 | -$267 | -$128 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$72 | -$175 | -$267 | -$128 |